Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03462342
Title Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer (CAPRI)
Acronym CAPRI
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.